SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-022296
Filing Date
2021-04-20
Accepted
2021-04-20 16:14:43
Documents
43
Period of Report
2021-02-28

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0221_bespokeextracts.htm 10-Q 325328
2 AMENDMENT NO. 5 TO DEBENTURE BETWEEN THE COMPANY AND THE VANTAGE GROUP LTD. f10q0221ex10-1_bespoke.htm EX-10.1 5696
3 AMENDMENT NO. 5 TO DEBENTURE BETWEEN THE COMPANY AND BERIQUE LABS LLC f10q0221ex10-2_bespoke.htm EX-10.2 5754
4 CERTIFICATION f10q0221ex31-1_bespoke.htm EX-31.1 14545
5 CERTIFICATION f10q0221ex32-1_bespoke.htm EX-32.1 5489
  Complete submission text file 0001213900-21-022296.txt   2314204

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE bspk-20210228.xml EX-101.INS 237563
7 XBRL SCHEMA FILE bspk-20210228.xsd EX-101.SCH 33539
8 XBRL CALCULATION FILE bspk-20210228_cal.xml EX-101.CAL 23783
9 XBRL DEFINITION FILE bspk-20210228_def.xml EX-101.DEF 172801
10 XBRL LABEL FILE bspk-20210228_lab.xml EX-101.LAB 316458
11 XBRL PRESENTATION FILE bspk-20210228_pre.xml EX-101.PRE 179529
Mailing Address 323 SUNNY ISLES BOULEVARD SUITE 700 SUNNY ISLES FL 33160
Business Address 323 SUNNY ISLES BOULEVARD SUITE 700 SUNNY ISLES FL 33160 855-633-3738
Bespoke Extracts, Inc. (Filer) CIK: 0001409197 (see all company filings)

IRS No.: 204743354 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52759 | Film No.: 21837993
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences